Shengmiao Fu
Papers
1
Total Citations
3
H-Index
1
About
Shengmiao Fu is a pioneering researcher at the intersection of single-cell omics, materials science, and ocular oncology, with a primary focus on uveal melanoma (UM)—the most common and deadly intraocular malignancy in adults. Fu’s landmark 2025 work, “Integrating single-cell omics and materials science for uveal melanoma: from mechanistic insights to precision therapeutics,” has already garnered 3 citations, signaling its rapid influence in the field. This seminal paper addresses UM’s devastating clinical challenges: its high metastatic potential, pronounced hepatic tropism, and poor prognosis after systemic spread. Fu’s major contribution lies in bridging molecular biology with advanced biomaterials, using single-cell technologies to unravel tumor heterogeneity and identify novel therapeutic targets, while simultaneously engineering precision delivery systems to overcome the blood-retinal barrier and liver tropism. By integrating mechanistic discovery with translational materials design, Fu has laid the groundwork for next-generation, patient-specific treatments that could transform outcomes for the nearly 50% of UM patients who develop fatal metastases. This work positions Fu as a rising leader in precision oncology, where the fusion of omics and materials science promises to redefine therapeutic strategies for aggressive, hard-to-treat cancers.
Research Focus
Key Achievements
Top Papers
- 1